91ÖÆƬ³§

Published on Market Research Reports® Inc. ()

Home > Global Breast Lesion Localization Methods Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Breast Lesion Localization Methods Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Publication ID: 
PB504255976
Publication Date: 
April 10, 2025
Pages: 
100
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 4,250.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

The global Breast Lesion Localization Methods market size was US$ 364 million in 2024 and is forecast to a readjusted size of US$ 486 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products.
The main market for breast lesion targeting methods is North America, which accounts for about 50% of the market, followed by Europe, which accounts for more than 25%.
Major companies include C.R. Bard, Cook Medical, Somatex Medical, Argon Medical Devices, Theragenics, etc., with the top three accounting for more than 80% of the market.
The global Breast Lesion Localization Methods market is strategically segmented by company, region (country), by Type, and by End User. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by End User for 2020-2031.
Market Segmentation
By Company:
C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB
By Type: (Dominant Segment vs High-Margin Innovation)
Wire Localization Biopsy
Radioisotope Localization
Magnetic Tracer
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Women
Men
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., C.R. BARD in Europe)
- Emerging Product Trends: Wire Localization Biopsy adoption vs. Radioisotope Localization premiumization
- Demand-Side Dynamics: Women growth in China vs. Men potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Breast Lesion Localization Methods market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Radioisotope Localization in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Men in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Breast Lesion Localization Methods value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Wire Localization Biopsy
1.2.3 Radioisotope Localization
1.2.4 Magnetic Tracer
1.2.5 Other
1.3 Market by End User
1.3.1 Global Market Share by End User: 2020 VS 2024 VS 2031
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Lesion Localization Methods Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Breast Lesion Localization Methods Revenue Market Share by Region (2020-2025)
2.4 Global Breast Lesion Localization Methods Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Breast Lesion Localization Methods Market Size and Prospective (2020-2031)
2.5.2 Europe Breast Lesion Localization Methods Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Breast Lesion Localization Methods Market Size and Prospective (2020-2031)
2.5.4 South America Breast Lesion Localization Methods Market Size and Prospective (2020-2031)
2.5.5 Middle East and Africa Breast Lesion Localization Methods Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Breast Lesion Localization Methods Historic Market Size by Type (2020-2025)
3.2 Global Breast Lesion Localization Methods Forecasted Market Size by Type (2026-2031)
3.3 Different Types Breast Lesion Localization Methods Representative Players
4 Breakdown Data by End User
4.1 Global Breast Lesion Localization Methods Historic Market Size by End User (2020-2025)
4.2 Global Breast Lesion Localization Methods Forecasted Market Size by End User (2026-2031)
4.3 New Sources of Growth in Breast Lesion Localization Methods Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Breast Lesion Localization Methods Players by Revenue (2020-2025)
5.1.2 Global Breast Lesion Localization Methods Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Breast Lesion Localization Methods Revenue
5.4 Global Breast Lesion Localization Methods Market Concentration Analysis
5.4.1 Global Breast Lesion Localization Methods Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Breast Lesion Localization Methods Revenue in 2024
5.5 Global Key Players of Breast Lesion Localization Methods Head office and Area Served
5.6 Global Key Players of Breast Lesion Localization Methods, Product and Application
5.7 Global Key Players of Breast Lesion Localization Methods, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Breast Lesion Localization Methods Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Breast Lesion Localization Methods Market Size by Type (2020-2025)
6.1.2.2 North America Breast Lesion Localization Methods Market Share by Type (2020-2025)
6.1.3 North America Market Size by End User
6.1.3.1 North America Breast Lesion Localization Methods Market Size by End User (2020-2025)
6.1.3.2 North America Breast Lesion Localization Methods Market Share by End User (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Breast Lesion Localization Methods Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Breast Lesion Localization Methods Market Size by Type (2020-2025)
6.2.2.2 Europe Breast Lesion Localization Methods Market Share by Type (2020-2025)
6.2.3 Europe Market Size by End User
6.2.3.1 Europe Breast Lesion Localization Methods Market Size by End User (2020-2025)
6.2.3.2 Europe Breast Lesion Localization Methods Market Share by End User (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Breast Lesion Localization Methods Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Breast Lesion Localization Methods Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Breast Lesion Localization Methods Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by End User
6.3.3.1 Asia-Pacific Breast Lesion Localization Methods Market Size by End User (2020-2025)
6.3.3.2 Asia-Pacific Breast Lesion Localization Methods Market Share by End User (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 South America Market: Players, Segments and Downstream
6.4.1 South America Breast Lesion Localization Methods Revenue by Company (2020-2025)
6.4.2 South America Market Size by Type
6.4.2.1 South America Breast Lesion Localization Methods Market Size by Type (2020-2025)
6.4.2.2 South America Breast Lesion Localization Methods Market Share by Type (2020-2025)
6.4.3 South America Market Size by End User
6.4.3.1 South America Breast Lesion Localization Methods Market Size by End User (2020-2025)
6.4.3.2 South America Breast Lesion Localization Methods Market Share by End User (2020-2025)
6.4.4 South America Market Trend and Opportunities
6.5 Middle East and Africa Market: Players, Segments and Downstream
6.5.1 Middle East and Africa Breast Lesion Localization Methods Revenue by Company (2020-2025)
6.5.2 Middle East and Africa Market Size by Type
6.5.2.1 Middle East and Africa Breast Lesion Localization Methods Market Size by Type (2020-2025)
6.5.2.2 Middle East and Africa Breast Lesion Localization Methods Market Share by Type (2020-2025)
6.5.3 Middle East and Africa Market Size by End User
6.5.3.1 Middle East and Africa Breast Lesion Localization Methods Market Size by End User (2020-2025)
6.5.3.2 Middle East and Africa Breast Lesion Localization Methods Market Share by End User (2020-2025)
6.5.4 Middle East and Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 C.R. BARD
7.1.1 C.R. BARD Company Details
7.1.2 C.R. BARD Business Overview
7.1.3 C.R. BARD Breast Lesion Localization Methods Introduction
7.1.4 C.R. BARD Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.1.5 C.R. BARD Recent Development
7.2 Cook Medical
7.2.1 Cook Medical Company Details
7.2.2 Cook Medical Business Overview
7.2.3 Cook Medical Breast Lesion Localization Methods Introduction
7.2.4 Cook Medical Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.2.5 Cook Medical Recent Development
7.3 Cianna Medical
7.3.1 Cianna Medical Company Details
7.3.2 Cianna Medical Business Overview
7.3.3 Cianna Medical Breast Lesion Localization Methods Introduction
7.3.4 Cianna Medical Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.3.5 Cianna Medical Recent Development
7.4 Eckert & Ziegler
7.4.1 Eckert & Ziegler Company Details
7.4.2 Eckert & Ziegler Business Overview
7.4.3 Eckert & Ziegler Breast Lesion Localization Methods Introduction
7.4.4 Eckert & Ziegler Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.4.5 Eckert & Ziegler Recent Development
7.5 Theragenics
7.5.1 Theragenics Company Details
7.5.2 Theragenics Business Overview
7.5.3 Theragenics Breast Lesion Localization Methods Introduction
7.5.4 Theragenics Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.5.5 Theragenics Recent Development
7.6 Argon Medical Devices
7.6.1 Argon Medical Devices Company Details
7.6.2 Argon Medical Devices Business Overview
7.6.3 Argon Medical Devices Breast Lesion Localization Methods Introduction
7.6.4 Argon Medical Devices Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.6.5 Argon Medical Devices Recent Development
7.7 SOMATEX Medical
7.7.1 SOMATEX Medical Company Details
7.7.2 SOMATEX Medical Business Overview
7.7.3 SOMATEX Medical Breast Lesion Localization Methods Introduction
7.7.4 SOMATEX Medical Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.7.5 SOMATEX Medical Recent Development
7.8 IsoAid
7.8.1 IsoAid Company Details
7.8.2 IsoAid Business Overview
7.8.3 IsoAid Breast Lesion Localization Methods Introduction
7.8.4 IsoAid Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.8.5 IsoAid Recent Development
7.9 Endomag
7.9.1 Endomag Company Details
7.9.2 Endomag Business Overview
7.9.3 Endomag Breast Lesion Localization Methods Introduction
7.9.4 Endomag Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.9.5 Endomag Recent Development
7.10 Ranfac
7.10.1 Ranfac Company Details
7.10.2 Ranfac Business Overview
7.10.3 Ranfac Breast Lesion Localization Methods Introduction
7.10.4 Ranfac Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.10.5 Ranfac Recent Development
7.11 STERYLAB
7.11.1 STERYLAB Company Details
7.11.2 STERYLAB Business Overview
7.11.3 STERYLAB Breast Lesion Localization Methods Introduction
7.11.4 STERYLAB Revenue in Breast Lesion Localization Methods Business (2020-2025)
7.11.5 STERYLAB Recent Development
8 Breast Lesion Localization Methods Market Dynamics
8.1 Breast Lesion Localization Methods Industry Trends
8.2 Breast Lesion Localization Methods Market Drivers
8.3 Breast Lesion Localization Methods Market Challenges
8.4 Breast Lesion Localization Methods Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-breast-lesion-localization-methods-sales-market-report-competitive-analysis-and

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare